Adaptive Biotechnologies Corporation - notizie pubblicate 188 - letture 6.394
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Amendment to Statement of Changes in Beneficial Ownership - Form 4/A
Ownership submission form 4/a check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and excha ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results - Form 8-K
Adaptive biotechnologies reports third quarter 2022 financial results seattle, nov. 3, 2022 (globe newswire) - adaptive biotechnologies corporation ("adaptive biotechnologies& ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Q3 2022 Earnings Presentation
Third quarter 2022 earnings conference call safe harbor this presentation has been prepared by adaptive biotechnologies corporation ("we," "us," "our," ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Quarterly Report for Quarter Ending September 30, 2022 (Form 10-Q)
10-q united states securities and exchange commission washington, dc 20549 form 10-q (mark one) ☒ quarterly report pursuant to section 13 or 15(d) of the securities exchange act ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results
Pdf version seattle, nov. 03, 2022 (globe newswire) -- adaptive biotechnologies corporation ("adaptive biotechnologies") (nasdaq: adpt), a commercial stage biotechnology ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Announces Partnership with Epic to Increase Access to Minimal Residual Disease (MRD) Monitoring in Blood Cancers
Pdf version integration with the most widely used comprehensive electronic health record will expand clinician and patient access to clonoseq seattle, oct. 11, 2022 (globe newswire ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million - Form 8-K
Adaptive biotechnologies announces non-dilutive royalty financing with orbimed for up to $250 million seattle, september 12, 2022 -- adaptive biotechnologies corporation (nasdaq: a ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies to Participate in the Morgan Stanley Global Healthcare Conference
Pdf version seattle, sept. 02, 2022 (globe newswire) -- adaptive biotechnologies corporation ("adaptive biotechnologies") (nasdaq: adpt), a commercial stage biotechnology ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Q2 2022 Earnings Presentation
Second quarter 2022 earnings conference call safe harbor this presentation has been prepared by adaptive biotechnologies corporation ("we," "us," "our,&quo ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
William Blair 42nd Annual Growth Stock Conference Presentation
William blair growth stock conference 2022 safe harbor this presentation has been prepared by adaptive biotechnologies corporation ("we," "us," "our," ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Investor Presentation - March 2022
Investor relations presentation march 2022 safe harbor this presentation has been prepared by adaptive biotechnologies corporation ("we," "us," "our," ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Q1 2022 Earnings Presentation
Safe harbor this presentation has been prepared by adaptive biotechnologies corporation ("we," "us," "our," "adaptive" or the "company& ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Q4 2021 Earnings Presentation
Fourth quarter and fy 2021 earnings conference call safe harbor this presentation has been prepared by adaptive biotechnologies corporation ("we," "us," "o ...
Sei un professionista?
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti